The role of human glutathione S-transferase isoenzymes in the formation of glutathione conjugates of the alkylating cytostatic drug thiotepa
- PMID: 7712478
The role of human glutathione S-transferase isoenzymes in the formation of glutathione conjugates of the alkylating cytostatic drug thiotepa
Abstract
Nonenzymatic and glutathione S-transferase (GST) catalyzed glutathione (GSH) conjugation has been postulated as a mechanism by which alkylating cytostatic drugs can be inactivated intracellularly. In this study, we describe studies on the glutathione-dependent biotransformation of thiotepa (tris(1-aziridinyl)phosphine sulfide), a trifunctional alkylating agent. 31P NMR studies showed that thiotepa is stable in 0.07 M phosphate buffer, pH 7.4 (t1/2 = 3300 min). In the presence of glutathione, the rate of disappearance of thiotepa increased greatly (t1/2 = 282 min). Both monoglutathionyl thiotepa and diglutathionyl thiotepa conjugates were identified by 31P NMR and mass spectrometry. Addition of GST A1-1 (alpha) to an incubation of thiotepa and GSH further increased the rate of disappearance of thiotepa (t1/2 = 100 min) and increased the rate of formation of monoglutathionyl thiotepa. The rate of formation of diglutathionyl thiotepa was not altered, suggesting that the formation of diglutathionyl thiotepa is not catalyzed by GST A1-1. The role of purified human GST on the formation of monoglutathionyl thiotepa was further studied by HPLC. In incubations with 0.2 mM thiotepa, 1 mM GSH, and 40 microM GST, both GST A1-1 and P1-1 enhanced the formation of the monoglutathionyl conjugate 30-35-fold above the nonenzymatic formation, while GST A2-2 and M1a-1a did not catalyze the rate of formation of this conjugate. Kms for the GST A1-1 (alpha) and P1-1 (pi) catalyzed formation of monoglutathionyl thiotepa were in the 5-7 mM range. Since the pH in tumors might be lower than in normal cells, the pH dependency of the GST P1-1 catalyzed formation of monoglutathionyl thiotepa was also studied. At all pHs tested (range, 5.5-8.5), a marked catalytic effect of both GST P1-1 and A1-1 on the formation of monoglutathionyl conjugates was noted. The role of GST on the formation of monoglutathionyl conjugates of tepa (tris(1-aziridinyl)phosphine oxide), the major metabolite formed from thiotepa, was also studied. Both GST A1-1 and P1-1 could enhance the formation of the glutathione conjugate 37-46-fold above the spontaneous levels, while GST M1a-1a and A2-2 again did not increase the rate of formation of this conjugate. The results of these studies show that the aziridine moieties in thiotepa/tepa are substrates for both GST A1-1 and P1-1. Thus, GST catalyzed glutathione conjugation of thiotepa might be an important factor in the development of drug resistance towards thiotepa.
Similar articles
-
Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione.Cancer Res. 1994 Dec 1;54(23):6215-20. Cancer Res. 1994. PMID: 7954469
-
Differential catalytic efficiency of allelic variants of human glutathione S-transferase Pi in catalyzing the glutathione conjugation of thiotepa.Arch Biochem Biophys. 1999 Jun 1;366(1):89-94. doi: 10.1006/abbi.1999.1217. Arch Biochem Biophys. 1999. PMID: 10334868
-
Glutathione conjugation of the cytostatic drug ifosfamide and the role of human glutathione S-transferases.Chem Res Toxicol. 1995 Oct-Nov;8(7):979-86. doi: 10.1021/tx00049a012. Chem Res Toxicol. 1995. PMID: 8555414
-
Review: In vivo models for measuring placental glutatione-S-transferase (GST-P 7-7) levels: a suitable biomarker for understanding cancer pathogenesis.In Vivo. 2012 Jul-Aug;26(4):647-50. In Vivo. 2012. PMID: 22773578 Review.
-
The glutathione biotransformation system and colorectal cancer risk in humans.Scand J Gastroenterol Suppl. 2001;(234):68-76. doi: 10.1080/003655201753265479. Scand J Gastroenterol Suppl. 2001. PMID: 11768564 Review.
Cited by
-
Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa.Br J Clin Pharmacol. 2009 Jan;67(1):50-60. doi: 10.1111/j.1365-2125.2008.03321.x. Epub 2008 Nov 17. Br J Clin Pharmacol. 2009. PMID: 19076156 Free PMC article.
-
Haplotype Inference Using Long-Read Nanopore Sequencing: Application to GSTA1 Promoter.Mol Biotechnol. 2025 Jun;67(6):2512-2519. doi: 10.1007/s12033-024-01213-7. Epub 2024 Jun 17. Mol Biotechnol. 2025. PMID: 38886308 Free PMC article.
-
A comprehensive understanding of thioTEPA metabolism in the mouse using UPLC-ESI-QTOFMS-based metabolomics.Biochem Pharmacol. 2011 Apr 15;81(8):1043-53. doi: 10.1016/j.bcp.2011.01.024. Epub 2011 Feb 12. Biochem Pharmacol. 2011. PMID: 21300029 Free PMC article.
-
Targeting the PI3K/Akt/mTOR axis by apigenin for cancer prevention.Anticancer Agents Med Chem. 2013 Sep;13(7):971-8. doi: 10.2174/18715206113139990119. Anticancer Agents Med Chem. 2013. PMID: 23272913 Free PMC article. Review.
-
Glutathione-S-transferase P1, T1 and M1 genetic polymorphisms in neoadjuvant-treated locally advanced gastric cancer: GSTM1-present genotype is associated with better prognosis in completely resected patients.Int J Colorectal Dis. 2008 Aug;23(8):773-82. doi: 10.1007/s00384-008-0490-4. Epub 2008 Apr 29. Int J Colorectal Dis. 2008. PMID: 18443805
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous